PSYREFLECT

Issue #18

March 5, 2026

#1Research

How Genocide Trauma Passes Between Generations: A Systematic Review of 36 Studies Shows Shared Mechanisms Across Cultures

Across 36 studies spanning Holocaust, Rwandan, Cambodian, and other genocide contexts, parenting disruption, attachment insecurity, and impaired family communication emerge as the same three transmission mechanisms — structurally identical across cultures, differing only in expression.

intergenerational-traumagenocideattachmentparenting
2 minRead analysis
#2Research

Does Adding Formal Meditation to ACT Improve Chronic Pain Outcomes? A Pilot RCT Says: Not Exactly — But Dose Matters

This pilot RCT (N=87) found ACT+mindfulness and CBT equally effective for chronic pain on average — but within the meditation group, daily practice was dose-dependently linked to greater depression and helplessness reduction. The question is not whether to add meditation, but which patients will practice and how to support them.

chronic-painACTmindfulnessmeditation
3 minRead analysis
#3Tool

The MPFI-24P: A 24-Item Tool That Maps Psychological Flexibility and Inflexibility in Chronic Pain Patients

The MPFI-24P gives ACT therapists what they have lacked: a 5-minute, 12-facet process measure that tracks which flexibility mechanisms are shifting and which are stuck — session by session, not just pre-post.

chronic-painpsychological-flexibilityACTassessment
2 minRead analysis
#4Industry

WHO Publishes a 9-Step Roadmap for Mental Health Deinstitutionalisation — And Calls Out "Mini-Institutions" in Community Care

WHO's new 9-step policy roadmap warns that deinstitutionalisation has stalled worldwide — not because hospitals remain, but because community services often replicate institutional cultures. The building got smaller; the institutional mindset stayed the same.

deinstitutionalisationmental-health-policyWHOcommunity-care
3 minRead analysis
#5Industry

FDA Approves First Fibromyalgia Drug in 15 Years — And It Is a Repurposed Muscle Relaxant, Not a Novel Mechanism

The FDA approved its first new fibromyalgia drug in 15 years — Tonmya, a sublingual reformulation of cyclobenzaprine. The innovation is not in the molecule but in the delivery: bypassing liver metabolism to keep the therapeutic effect while reducing daytime sedation. For the 54% of fibromyalgia patients with comorbid depression, the simultaneous improvement in pain, sleep, and fatigue may create better conditions for psychological treatment.

fibromyalgiachronic-painpharmacotherapyFDA-approval
2 minRead analysis
#6Resource

PESI's Somatic Therapy for Complex Trauma Certification: 43 CE Hours with Fisher, Schwartz, and Blakeslee

PESI's 43-hour somatic trauma certification with Fisher, Schwartz, and Blakeslee fills the gap between weekend workshops and multi-year SE certification — structured enough to be clinically meaningful, practical enough for working clinicians who cannot pause their practice for three years.

somatic-therapycomplex-traumacontinuing-educationcertification
3 minRead analysis